Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment

Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs).

Biden initiative aims to accelerate women’s health research

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The White House on Monday

November 14, 2023

New method could make post-stroke motor rehabilitation more effective and affordable

The longest nerve in the human body starts in the brain and meanders its way down the neck and into the chest, where it splits

July 19, 2023

Caris and Merck partner to develop ADCs for cancer treatment

Share this article Merck KGaA will hold the responsibility for executing the preclinical and clinical research of the ADC programmes. Credit: © Merck KGaA, Darmstadt,

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.